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Previously, we found that 5–25 μg/ml safrole oxide could inhibit apoptosis and dramatically make a morphological change in human umbilical
vein vascular endothelial cells (HUVECs). But the possible mechanism by which safrole oxide function is unknown. To answer this question, in
this study, we first investigated the effects of it on the activity of nitric oxide synthetase (NOS), the expressions of Fas and integrin β4, which play
important roles in HUVEC growth and apoptosis, respectively. The results showed that, at the low concentration (10 μg/ml), safrole oxide had no
effects on NOS activity and the expressions of Fas and integrin β4. Then, we investigated whether HUVECs underwent differentiation. We
examined the expressions of neuron-specific enolase (NSE) and neurofilament-L (NF-L). Furthermore, we analyzed the changes of intracellular
reactive oxygen species (ROS). After 10 h of treatment with 10 μg/ml safrole oxide, some HUVECs became neuron-like cells in morphology, and
intensively displayed positive NSE and NF-L. Simultaneously, ROS levels dramatically decreased during HUVECs differentiation towards
neuron-like cells. At the low concentration, safrole oxide induced HUVECs differentiation into neuron-like cells. Furthermore, our data suggested
that safrole oxide might perform this function by depressing intracellular ROS levels instead of by affecting cell growth or apoptosis signal
pathways.
© 2006 Elsevier B.V. All rights reserved.Keywords: Safrole oxide; HUVEC; Differentiation; Neuron1. Introduction
Vascular endothelial cells (VEC) have very important roles
in vascular development and in maintaining the normal
functions of blood vessels. The coordinated regulation of
vascular endothelial cell growth, apoptosis, and differentiation
is essential for the normal functions of VEC. There are growth
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doi:10.1016/j.bbamcr.2006.01.002differentiation signal pathways in VECs. It has been reported
that targeted deficiency or cytosolic truncation of the VE-
cadherin gene in mice impairs VEGF-mediated endothelial
survival and angiogenesis [1]. The results of this report
showed that blockade of growth signaling pathways in VECs
could lead to vascular defects during embryonic development
due to increased endothelial cell apoptosis, significantly,
endothelial cell proliferation and differentiation were not
affected [1]. The data suggested that when the VEGF-
mediated growth signaling pathways were impaired, VECs
could select apoptosis or differentiation during embryonal
development.
It has been shown that FGFs also play important roles in
embryonic development, angiogenesis, wound healing and
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stronger mitogen for VECs than VEGF in vitro [2,3]. Thus,
controlling VEC growth stimulated by bFGF is a promising
new approach in vascular development research and cancer
therapy [4]. We have been studying the growth mediated by
bFGF and the apoptosis induced by deprivation of bFGF in
HUVECs. Our previous experiment results showed that
integrin β4 was a key membrane protein in HUVEC
apoptosis induced by deprived of bFGF [5–8]. Apoptosis
of VEC is likely regulated by survival and death signals.
Among the survival signals, NOS is an important element
[9]. Activation of the endothelial NOS, leads to enhanced
synthesis of NO, which promotes HUVEC survival. Inhibi-
tion of the survival signaling pathways mediated by NO
caused massive HUVEC apoptosis [10]. Recently, we found
a small molecule, safrole oxide, could trigger HUVEC
apoptosis by upregulating of Fas, integrin β4 and depressing
of ROS level at high concentrations [11]. These data indicate
that NOS, Fas and integrin β4 are important elements and
may have some relations in controlling HUVEC growth and
apoptosis.
On the other hand, we observed that, when HUVECs were
exposed to safrole oxide of low concentrations (5–25 μg/ml),
the apoptosis induced by deprivation of bFGF was inhibited
and some cells became neuron-like cells in morphology [12].
This finding initiated us to study the possible mechanism by
which safrole oxide acts in HUVECs at the low concentration.
To our knowledge, it is the first report that, at the low
concentration, safrole oxide could induce HUVECs differen-
tiation into neuron-like cells by depressing intracellular ROS
levels instead of by affecting cell growth or apoptosis signal
pathways.
2. Materials and methods
2.1. Reagents
Safrole oxide [3,4-(methylenedioxy)-1-(2′,3′-epoxypropyl)-benzene] was
synthesized by the reaction of safrole with 3-chloroperoxybenzoic acid and
purified by silica gel column chromatography [13]. It was dissolved in
ethanol and applied to cells such that the final concentration of ethanol in
the culture medium was below 0.01% (vol/vol). Ethanol at a concentration
of 0.1% (vol/vol) did not affect the viability of the cells. M199 medium was
purchased from Gibco BRL Co., Grand Island, NY. DCHF (2′,7′-
dichlorofluorescin) was purchased from Sigma, Co. USA. Fetal bovine
serum (FBS) was purchased from Hyclone Lab Inc. USA. Basic fibroblast
growth factor (bFGF) was extracted from bovine brains by the method of
Lobb and Fett [14] in our laboratory. Primary antibodies (Rabbit anti-rat
neuron-specific enolase (NSE), neurofilament-L (NF-L) and Mouse anti-
human integrin β4) and secondary antibody (FITC- IgG) were purchased
from Santa Cruz Co. Nitric oxide synthase (NOS) detection kit was
purchased from Nanjing Jiancheng Co. All other reagents were ultrapure
grade.
2.2. Cell cultures
Human umbilical vein endothelial cells (HUVEC) were obtained in our
laboratory by using the method of Jaffe et al. [15]. The cells were cultured on
gelatin-coated plastic dishes with M199 medium that was supplemented with
20% FBS and bFGF 70 mg/ml at 37 °C in 5% CO2/95% air (normal group). All
experiments were performed on the cells from 10 to 20 passages.2.3. Exposure of HUVECs to safrole oxide
HUVECs were washed once with the medium and divided into two groups
when the cultures of HUVECs reached sub-confluence: in control group, cells
were cultured in the medium without bFGF and serum; in safrole oxide-treated
group, the cells deprived of bFGF and serum were treated with 10 μg/ml safrole
oxide for 10 h, 24 h and 48 h. The morphological changes of the cells were
observed under phase contrast microscope (Nikon, Japan).
2.4. Cell viability analysis
Cells were seeded into 96-well plates and divided into three groups: in
normal group, cells were cultured in the supplemented medium with bFGF and
serum; in control group, cells were cultured in the medium without bFGF and
serum; in safrole oxide-treated group, the cells deprived of bFGF and serum
were treated with 5 μg/ml, 10 μg/ml and 25 μg/ml safrole oxide, respectively for
24 h. Cell growth was determined by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium) (Sigma Chemical Co. USA) assay. After cells were treated
with safrole oxide 6 h, 20 μl of MTT (5 mg/ml) in PBS solution was added to
each well and then the plate was further incubated for 4 h. All remaining
supernatant were removed and 100 μl of DMSO was added to each well and
mixed thoroughly to dissolve the formed crystal formazan. After 10 min of
incubation to ensure all crystals were dissolved, the light absorption was
measured at 570 nm using SpectraMAX 190 microplate spectrophotometer
(GMI co., USA).
2.5. Immunofluorescence assay
Immunofluorescence was performed on subconfluence cells after treatment
for 10 h with safrole oxide to examine the expression of integrin β4. The cells
were washed with 0.1M phosphate-buffered saline (PBS), fixed with 4%
paraformaldehyde for 10 min. After washing with 0.1 M PBS, they were
incubated with 30%H2O2/methyl (1/9 vol/vol) for 5 min and blocked with sheep
serum diluted at 1:50 in 0.1 M PBS for 20 min at room temperature. Then,
primary antibodies (mouse anti-human integrin β4) were added and incubated in
a humid chamber over night at 4 °C. PBS, 0.1 M, replaced primary antibodies as
negative control. After washing with 0.1 M PBS, secondary antibodies (goat
anti-mouse) were added and incubated for 20 min at 37 °C. After washing with
0.1M PBS, samples were evaluated with laser scanning confocal microscopy
(Leica, Germany). The immunofluorescence techniques allow semiquantitative
evaluation of protein expression [16].
2.6. Western immunoblot analysis
Cells were cultured in the absence or presence of safrole oxide for 10 h. The
total protein of the cells was prepared as described by Lipscomb E.A. [17]. The
concentration of each protein lysate was determined by the Bradford Protein
Assay [18]. Equal amount of total protein was loaded on 7.5% SDS-
polyacrylamide gel and electrophoretically transferred to nitrocellulose transfer
membrane (Amersham Pharmacia Biotech., USA). After blocking with 5% skim
milk in PBS, 0.5% (vol/vol) Tween 20 for 1 h, the membrane was incubated with
monoclonal Fas protein antibody (mouse anti human) overnight at 4 °C, then
incubated with HRP-linked secondary antibodies (goat anti mouse) for 1 h at
room temperature (RT), followed by color development with 0.06% DAB
(diaminobenzidine) and 0.03% H202 in PBS for 3–5 min, at RT. Distilled water
was used to cease the reaction. Monoclonal anti-β-actin antibody (mouse anti
human) was used to ascertain that equal amount of protein was loaded. The
relative quantity of protein was analyzed by Imagetool software.
2.7. NOS activity assay
For the preparation of enzymes, after harvested and washed, the cells
(1×106) were homogenized with ultrasonic (400W, 12 min) in 3 ml buffer A (20
mM Tris–HCl, pH 7.0, 10 mM EGTA, 1 mM EDTA, 1 mM DTT, 1 mM PMSF,
0.34 mM sucrose) on ice. After centrifuged at 800 rpm, 4 °C for 15 min, the
supernatant was centrifuged again at 100,000 rpm, 4 °C for 1 h, then, was used
for NOS activity assay.
Fig. 1. Effect of safrole oxide on the viability of HUVECs at 24 h.
Normal group, the viability of HUVECs cultured in the supplemented
medium with bFGF and serum; control group, the viability of HUVECs
cultured in the basal medium without bFGF and serum; 5 μg/ml, 10 μg/
ml and 25 μg/ml group, the viability of HUVECs treated with 5 μg/ml,
10 μg/ml and 25 μg/ml safrole oxide, respectively. *Pb0.05 vs. #, **Pb0.01 vs.
#n=3.
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NOS detection kit (Nanjing Jiancheng Company, China). The optical density
was measured at 530 nm (wavelength). The enzyme activity was expressed as U
per mg of protein (U/mg prot).
2.8. Immunohistochemistry
To explore whether HUVECs treated with 10 μg/ml safrole oxide underwent
differentiation, we used immunohistochemistry method to examine the
expressions of NSE and NF-L. HUVECs after treatment were washed three
times for 5 min with 0.01 M PBS. Cells were blocked with normal goat serum
for 20 min at room temperature. Then, primary antibodies (rabbit anti-NSE IgG
or rabbit anti-NF-L IgG) were added and cells were incubated in a humid
chamber overnight at 4 °C. After washing three times for 5 min with 0.01 M
PBS, secondary antibodies (FITC-goat anti-rabbit IgG) were added and
incubated for 30 min at 37 °C. After washing 4 times for 5 min with 0.01 M
PBS, the samples were evaluated with Laser Scanning Confocal Microscope
(Leica, Germany).
2.9. ROS assay
Intracellular ROS levels were measured using a fluorescent probe, 2′,7′-
dichlorodihydrofluorescein (DCHF, Sigma Co. USA), which could be rapidly
oxidized into the highly fluorescent 2′,7′-dichlorofluorescein (DCF) in the
presence of intracellular ROS. This assay is a reliable method for the
measurement of intracellular ROS [19].
We treated cells in two ways mentioned above for 10 h, then washed cells
with basal M199 medium (without bFGF and FBS) one time for 5 min, and
incubated the cells with DCHF 0.5 ml at 37 °C for 30 min. After washing the
cells three times for 5 min with basal M199 medium (without bFGF and FBS),
we quantified the levels of ROS in HUVECs by the software of Leica Laser
Scanning Confocal Microscope. The photographs were representatives in the
scan rooms.
2.10. Statistical analysis
Data were expressed as mean±S.E. and accompanied by the number of
experiments performed independently. Statistical analysis was done by t test,
and differences at Pb0.05 were considered statistically significant.3. Results
3.1. Effect of safrole oxide on the viability of cells
When the cells were deprived of bFGF and serum, the
viability of cells decreased. After exposure of HUVECs to 5–25
μg/ml safrole oxide for 24 h, the viability was elevated.
Especially, 10 μg/ml safrole oxide markedly increased the cell
viability (Pb0.01) (Fig. 1). The most effective concentration of
safrole oxide is 10 μg/ml, so in all experiments of this study, 10
μg/ml safrole oxide was used.
3.2. Cell morphological changes
When HUVECs were exposed to 10 μg/ml safrole oxide,
many cells changed in morphology. Generally, cell bodies
became longer, cytoplasm in HUVECs retracted towards the
nucleus, forming a triangular cell body and process-like
extensions peripherally. Some of the cell bodies became very
similar to neurons (Fig. 2C). There were no obvious
morphological changes in the control group cells (Fig. 2B).
Compared with the cells exposed to 10 μg/ml safrole oxidefor 10 h (Fig. 2C), the cells treated for 24 h and 48 h (Fig.
2D and E) were much longer. Usually, the expressions of
specific proteins would change before the cell morphological
change. So we did all experiments at 10 h after the start of
the treatment in this study.
3.3. Effect of safrole oxide on the expression of Fas
Fas is a key factor in apoptosis signal transduction pathway,
to understand whether safrole oxide affects the apoptosis
signaling in HUVECs, we investigated the effects of safrole
oxide on the expression of Fas. After the cells were treated with
safrole oxide for 10 h the levels of Fas protein were analyzed by
Western blot analysis. The results revealed that the levels of Fas
protein were not changed significantly in the cells treated by 10
μg/ml safrole oxide (Fig. 3A and B). Therefore, 10 μg/ml
safrole oxide could not affect the apoptosis signal pathway
mediated by Fas.
3.4. Effect of safrole oxide on the expression of integrin β4
Integrin β4 is a more important factor in HUVEC
apoptosis [5–8]. In order to know whether safrole oxide
acts in the cells by affecting the function of integrin β4, the
cells were exposed to 10 μg/ml safrole oxide for 10 h, then
the levels of integrin β4 expression were detected by
immunofluorescence assay. As shown in Fig 4, the level of
integrin β4 in the cells treated by safrole oxide was also not
altered significantly (PN0.05). The results showed that, at the
low concentration, safrole oxide had no effect on the apoptosis
signaling mediated by integrin β4.
3.5. Effect of safrole oxide on the activity of NOS
NOS has important roles in HUVEC survival. To
understand the effect of safrole oxide on the growth signal
pathway of HUVECs, we examined the activity of NOS in
the cells treated with safrole oxide. The results showed that
there was no difference in NOS activity between control
group and safrole oxide treated group (PN0.05) (Fig. 5).
Fig. 2. The morphological changes of HUVECs treated with 10 μg/ml safrole oxide. (A) The cells cultured in the medium with bFGF and serum. (B) The cells cultured
in the basal medium without bFGF and serum. (C) The cells treated with 10 μg/ml safrole oxide in the basal medium for 10 h. (D) The cells treated with 10 μg/ml
safrole oxide in the basal medium for 24 h. (E) The cells treated with 10 μg/ml safrole oxide in the basal medium for 48 h (×200).
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To demonstrate whether the cells treated by safrole oxide
differentiate into neuron-like cells, we examined the expres-
sions of NSE and NF-L which were the specific markers of
neurons. The results revealed that the expressions of NSE and
NF-L in the cells treated with safrole oxide were positive (Fig.
6B and D), while in the control groups, the expressions of NSE
and NF-L were not detected (Fig. 6A and C). These results
showed that safrole oxide could induce HUVECs differentiation
into neuron-like cells.Fig. 3. Effects of safrole oxide on the expression of Fas. (A) The bands of
proteins by Western blot assay. (B) The relative quantity of Fas protein depicted
as a bar chart. Control group, the relative quantity of Fas protein from the cells
cultured in the basal medium; treatment group, the relative quantity of Fas
protein from the cells treated with 10 μg/ml safrole oxide (PN0.05). &PN0.05
vs. #n=3.3.7. Effect of safrole oxide on the level of ROS
We wonder why safrole oxide could induce HUVECs
differentiation. ROS acts as intracellular messengers in signal
transduction pathways, especially in cell differentiation signal
pathway [21]. To understand whether ROS is involved in
HUVEC differentiation caused by safrole oxide, we detected the
levels of intercellular ROS in the cells. After treating the cells
with safrole oxide for 10 h, we detected the levels ofFig. 4. Effects of safrole oxide on the level of integrin β4 expression.
Fluorescent micrographs show the relative intensity of integrin β4 in HUVECs.
(A) Cells cultured in the basal medium, and (B) Cells treated with 10 μg/ml
safrole oxide. (C) The quantity of expressed integrin β4. The value in the figures
represents the relative fluorescent intensity per cell determined by laser scanning
confocal microscopy 10 h after the start of treatment. Control group, the relative
quantity of integrin β4 from the cells cultured in the basal medium; treatment
group, the relative quantity of integrin β4 from the cells treated with 10 μg/ml
safrole oxide (PN0.05). &PN0.05 vs. #n=3.
Fig. 7. The levels of intracellular ROS during HUVEC differentiation into
neuron-like cells. Fluorescent micrographs show the relative intensity of ROS.
(A) Cells cultured in the basal medium for 10 h, and (B) Cells treated with 10
μg/ml safrole oxide. (C) The quantity of intracellular ROS levels. Control
group, the ROS level of the cells cultured in the basal medium; treatment
group, the ROS level of the cells treated with 10 μg/ml safrole oxide
(Pb0.01). **Pb0.01 vs. #n=3.
Fig. 5. Effects of safrole oxide on the NOS activity. Control group, the NOS
activity of the cells cultured in the basal medium; treatment group, the NOS
activity of the cells treated with 10 μg/ml safrole oxide (PN0.05). &PN0.05
vs. #n=3.
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intensity of DCF was very high in the control group cells, but
when the cells were treated with 10 μg/ml safrole oxide, the
fluorescent intensity decreased significantly (Pb0.01). The
results revealed that safrole oxide could effectively depress the
level of ROS in HUVECs.
4. Discussion
Safrole oxide has piperonyl and epoxy structures, which are
important in many compounds with physiological activity [22].
In our previous study, safrole oxide was synthesized and its
effect on the growth and apoptosis of HUVECs was examined
to provide experimental evidence for its clinical trial. We found
that 5–25 μg/ml safrole oxide inhibited, but 50–100 μg/ml
promoted apoptosis of HUVECs. Our finding suggested that
safrole oxide might be an important small molecule that affects
HUVEC growth and apoptosis [12]. In this study, we further
investigated the possible mechanism by which safrole oxideFig. 6. The differentiation of HUVECs induced by safrole oxide. (A) Cells in
control group exhibited NSE negative. (B) Cells treated with safrole oxide
exhibited NSE positive. (C) Cells in control group exhibited NF-L negative. (D)
Cells treated with safrole oxide exhibited NF-L positive. The experiment was
repeated three times with similar results.functions at the low concentration. The results showed that 10
μg/ml safrole oxide could induce HUVECs differentiation into
neuron-like cells by depressing intracellular ROS levels instead
of by affecting cell growth or apoptosis signal pathways.
Cells can take apoptosis, growth or differentiation signals in
vitro and in vivo. Among the growth signals, NOS is an
important element to HUVEC survival [9,10]. Activation of the
endothelial NOS leads to enhanced synthesis of NO, which
promotes endothelial cell survival by inhibiting the activity of
cysteine protease (caspase). Inhibition of the survival signaling
pathways mediated by NO caused massive HUVEC apoptosis
[10,23]. However, our data in this study showed that 10 μg/ml
safrole oxide did not affect the activity of NOS (PN0.05),
suggesting that safrole oxide at the low concentration could not
induce HUVEC growth by NOS.
Fas (also called APO-1 or CD95) is a type I membrane
protein belonging to the TNF receptor family that functions to
transmit a death signal in many kinds of cells. Although,
activation of the classical apoptotic APO-1/Fas pathway in
HUVEC using Fas ligand is discussed controversially, recent
reports showed that Fas could participate in HUVEC apoptosis
induced by several kinds of reagents [24–27]. In this study, 10
μg/ml safrole oxide could not affect the expression of Fas
(PN0.05). The results indicated that it might not function in
HUVECs by affecting the apoptosis signal pathway mediated
by Fas at the low concentration.
Integrin β4 is a more important factor in HUVEC apoptosis
[5–8]. To further explore whether safrole oxide acts in the cells
by affecting the expression of integrin β4, we examined the
level of integrin β4. The results showed that 10 μg/ml safrole
oxide also could not affect the expressions of integrin β4
(PN0.05). The data indicated that it might not act in HUVECs
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β4 at the low concentration.
While HUVECs treated with 10 μg/ml safrole oxide did not
take growth or apoptosis pathway, it might take differentiation.
In order to prove it, we first examined the expressions of the
specific markers of neurons, NSE and NF-L. The experiment
results showed that the expressions of NSE and NF-L were
obviously positive, suggesting that differentiated cells induced
by safrole oxide were neuron-like cells. The data indicated that
10 μg/ml safrole oxide could induce HUVECs differentiation
into neuron-like cells in vitro.
To know why safrole oxide can inhibit apoptosis [12]
and induce cell differentiation in HUVECs at the low
concentration, we analyzed the effect of safrole oxide on the
level of intracellular ROS which acted as intracellular
messengers in signal transduction pathways [21]. The results
told us safrole oxide could dramatically depress the ROS
level in HUVECs.
Recent studies show that endothelial productions of ROS
lead to cell death or promote dysfunction [28]. Especially,
nontoxic levels of ROS may play an essential role as signaling
molecules regulating cell growth and differentiation [21]. Our
previous study also showed that elevating ROS levels triggered
apoptosis in HUVECs [20]. In this study, the data suggested that
safrole oxide could inhibit apoptosis by depressing the levels of
ROS in HUVECs.
It has been reported that many antioxidants can induce MSCs
differentiation into neurons, such as b-mercaptoethanol (BME),
butylated hydroxyanisole (BHA), and dimethyl sulphoxide
(Me2SO) [29]. The antioxidant activity was proposed as a
generalized stimulus for cell differentiation during development
[30]. In this study, we found that safrole oxide depressed the
levels of ROS and induced HUVECs differentiated into neuron-
like cells. The data suggested that this small molecule might act
through the redox signal system in this process.
In addition, recently, ROS was suggested as inducers of
neuronal differentiation [31,32], and some findings indicate that
HUVECs have the potential to differentiate into smooth muscle-
like cells [33]. Our present data suggested that HUVECs could
be induced to differentiate into neuron-like cells by safrole
oxide, and it might perform this function by depressing the
levels of ROS.
The phenomenon that an irreversible switch of one type of
already differentiated cell to another type of normal differen-
tiated cell in postnatal life was defined as transdifferentiation
[34]. Our previous experiment results showed that the
differentiated HUVECs was induced to differentiate into
neuron-like cells by an antioxidant, D609 [35]. In this study,
the results showed that safrole oxide at low concentrations
could induce HUVEC differentiation into neuron-like cells by
depressing the intracellular ROS level. These data suggested
that HUVECs had the transdifferentiation potential, and their
transdifferentiation to neuron-like cells might be regulated by
ROS signal pathways.
Taken together, a critical balance between the synthesis and
destruction of ROS is likely to regulate the balance among the
cellular processes of proliferation, differentiation, and apopto-sis. Our data suggested that safrole oxide was a useful small
molecule to affect the balance of cell proliferation, differenti-
ation, and apoptosis in HUVECs, although the target of safrole
oxide needs to be defined. This finding encourages us to
investigate the mechanisms of HUVEC differentiation and
apoptosis from the point of view of chemical genetics by safrole
oxide.
In summary, our results showed that 10 μg/ml safrole oxide
had no effects on NOS activity and the expressions of Fas and
integrin β4. But it could induce HUVEC transdifferentiation
into neuron-like cells, at the same time, intracellular ROS levels
dramatically decreased. The data suggested that safrole oxide
might perform its functions by depressing intracellular ROS
levels instead of by affecting cell growth or apoptosis signal
pathways. Our next goal is to define the target of safrole oxide
in redox signaling pathways that control cell differentiation and
apoptosis.
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